From: Health and economic impact of rotavirus vaccination in GAVI-eligible countries
No | Scale-up scenarios | No. of children vaccinated (in million) | No. of outpatient visits averted (r = 0%) (in million) | No. of hospitalization averted (r = 0%) (in million) | No. of deaths averted (r = 0%) (in million) | YL saved (r = 3%) (in million) | DALYs averted (r = 3%) (in million) |
---|---|---|---|---|---|---|---|
1 | Base-case rollout scenario (Table 2) | Â | Â | Â | Â | Â | Â |
 | Vaccine efficacy based on the SAGE approach |  |  |  |  |  |  |
 | Vaccine immunity waning (14% annually) | 281.8 | 40.7 | 4.5 | 0.9 | 20.3 | 20.4 |
2 | Base-case rollout scenario (Table 2) | Â | Â | Â | Â | Â | Â |
 | Vaccine efficacy based on the SAGE approach |  |  |  |  |  |  |
 | No vaccine immunity waning | 281.8 | 44.1 | 4.9 | 1.0 | 22.0 | 22.1 |
3 | Base-case rollout scenario (Table 2) | Â | Â | Â | Â | Â | Â |
 | Vaccine efficacy adjusted for serotype distribution |  |  |  |  |  |  |
 | Vaccine immunity waning (14% annually) | 281.8 | 47.8 | 5.6 | 1.2 | 25.3 | 25.4 |
4a | Base-case rollout scenario (Table 2) | Â | Â | Â | Â | Â | Â |
 | Vaccine efficacy adjusted for serotype distribution |  |  |  |  |  |  |
 | No vaccine immunity waning | 281.8 | 51.7 | 6.0 | 1.3 | 27.3 | 27.4 |
5 | (Modified) Wolfson et al. scenario [37] | Â | Â | Â | Â | Â | Â |
 | Vaccine efficacy based on the SAGE approach |  |  |  |  |  |  |
 | No vaccine immunity waning | 410.5 | 64.2 | 7.7 | 1.6 | 35.6 | 35.7 |
6 | (Modified) Wolfson et al. scenario [37] | Â | Â | Â | Â | Â | Â |
 | Vaccine efficacy adjusted for serotype distribution |  |  |  |  |  |  |
 | No vaccine immunity waning | 410.5 | 81.4 | 10.4 | 2.2 | 48.1 | 48.3 |
7 | A flat coverage of 70% | Â | Â | Â | Â | Â | Â |
 | Vaccine efficacy based on the SAGE approach |  |  |  |  |  |  |
 | No vaccine immunity waning | 537.0 | 85.9 | 10.1 | 2.1 | 48.9 | 49.1 |
8 | A flat coverage of 70% | Â | Â | Â | Â | Â | Â |
 | Vaccine efficacy adjusted for serotype distribution |  |  |  |  |  |  |
 | No vaccine immunity waning | 537.0 | 106.6 | 13.3 | 2.8 | 64.5 | 64.7 |